Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01209260 · ClinicalTrials.gov registry record · NA

Transseptal Needle Versus Radiofrequency Energy for Left Atrial Access

A NA study of Heart Diseases, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
72
Enrollment target
1
Study location

NCT01209260 is a NA study of Heart Diseases that has completed, run by University of California, San Francisco. The registered enrollment target is 72 participants, below the 5,531-participant average among 85 other Heart Diseases trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01209260, a NA study of Heart Diseases, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
72 participants
Enrollment target
1
Study location

Study Summary

This is a randomized controlled trial examining whether a mechanical needle versus a needle that uses radiofrequency energy is better at puncturing through a thin wall in the heart (called "transseptal puncture") as measured by procedure time, during an electrical procedure/study of the heart .

Conditions Studied

Interventions

  • DEVICE Radiofrequency energy needle
  • DEVICE Mechanical Needle

Study Locations (1)

California

  • University of California, San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2010-11
Est. Completion 2012-11
Phase NA

What the Registry Record Tells You About NCT01209260

The ClinicalTrials.gov registry entry for NCT01209260 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,531-participant average among 85 other Heart Diseases trials with a reported enrollment target (99% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Heart Diseases appearing as the primary indexed condition, and to 2 interventions - of which Radiofrequency energy needle is the first listed.

NCT01209260 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT01209260 about?

NCT01209260 is a clinical study titled "Transseptal Needle Versus Radiofrequency Energy for Left Atrial Access". This is a randomized controlled trial examining whether a mechanical needle versus a needle that uses radiofrequency energy is better at puncturing through a thin wall in the heart (called "transseptal puncture") as measured by procedure time, during an electrical procedure/study of the heart .

What is the current status of trial NCT01209260?

This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2010-11. Estimated completion is 2012-11.

What conditions does trial NCT01209260 study?

This clinical trial studies the following conditions: Heart Diseases.

What interventions are being tested in trial NCT01209260?

The interventions under investigation include: Radiofrequency energy needle (DEVICE), Mechanical Needle (DEVICE).

Who is sponsoring clinical trial NCT01209260?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01209260 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.